| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | ORIC PHARMACEUTICALS, INC. | 11.95% | 5.64% | -75.78% | -85.56% | --.--% | 126 |
| | | | | | | |
| GILEAD SCIENCES, INC. | 0.51% | 1.50% | -10.76% | -1.67% | -3.12% | 80 866 |
| REGENERON PHARMACEUTICALS, INC. | 1.37% | 4.79% | 9.70% | 39.86% | 121.65% | 73 638 |
| VERTEX PHARMACEUTICALS | 1.51% | 5.85% | 24.65% | 32.04% | 59.36% | 68 965 |
| BIONTECH SE | 5.57% | -5.79% | -35.24% | -15.55% | --.--% | 38 433 |
 | WUXI APPTEC CO., LTD. | 4.97% | -5.16% | -22.01% | -34.41% | 170.57% | 37 870 |
 | GENMAB A/S | -0.61% | -0.71% | -19.73% | -12.91% | 76.36% | 19 941 |
 | ARGENX SE | 2.25% | -1.64% | -4.76% | 33.53% | 148.59% | 17 213 |
| BEIGENE, LTD. | 2.06% | -2.45% | -50.56% | -61.84% | 5.81% | 13 543 |
| NEUROCRINE BIOSCIENCES, INC. | 3.63% | 8.03% | 9.31% | -4.17% | 16.54% | 8 587 |
| HALOZYME THERAPEUTICS, INC. | 3.65% | 6.30% | 20.12% | 15.69% | 213.43% | 6 420 |
| SAREPTA THERAPEUTICS, INC. | 5.29% | 4.95% | -17.10% | -2.88% | -38.22% | 6 204 |
| LEGEND BIOTECH CORPORATION | 8.59% | 0.28% | -8.32% | 11.02% | --.--% | 6 069 |
| EXELIXIS, INC. | 1.15% | 3.60% | 0.66% | -18.15% | -9.63% | 5 834 |
| INTRA-CELLULAR THERAPIES, INC. | -0.75% | 0.69% | 11.35% | 47.47% | 332.67% | 5 539 |
 | BIOCON LIMITED | 2.34% | 0.90% | -8.68% | -12.80% | 20.89% | 4 984 |
| | | | | | | |
| | Durchschnitt | 2.77% | 1.41% | -6.76% | 1.02% | 85.76% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 2.17% | 1.41% | -4.38% | 7.10% | 76.04% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
